In the current pursuit of innovation and breakthroughs in the biomedical field, new drugs have brought new hope for the treatment of numerous diseases and the improvement of human health
Short NJ, Garcia-Manero G, Naqvi K, Kornblau S, Takahashi K, Montalban-Bravo G, Khouri R, Andreeff M , Konopleva M, DiNardo CD, Alvarado Y, Ghosn M, Estrov Z, Bose P, Islam R, Dong X, Cortes JE, Kantarjian HM, Jabbour EJ
A 10-m size nebulizer was used for the exposures
The GPX4 inhibitors could downregulate GPX4 and selectively reduce the residual CRC persister cell pool in vitro
Briefly, 2 10 7 cells were lysed in 600 l of PLB buffer (100 mM KCl, 5 mM MgCl 2 , 10 mM HEPES pH 7.0 and 0.5% NP-40) with RNaseOUT recombinant ribonuclease inhibitor (Invitrogen, 10777019) and protease inhibitor (APExBIO, k1007) and 12 l of lysate was saved as input